Cargando…
A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development
Since the beginning of 2020, the world has been in a race to develop vaccines that can control the COVID-19 pandemic. More than 250 projects have been initiated for this purpose, but only 14 of them have been authorized for use, despite being in phase 3 clinical trials. More than 40 other vaccines a...
Autores principales: | Abdulla, Zainalabideen A., Al-Bashir, Sharaf M., Al-Salih, Noor S., Aldamen, Ala A., Abdulazeez, Mohammad Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308489/ https://www.ncbi.nlm.nih.gov/pubmed/34206507 http://dx.doi.org/10.3390/pathogens10070788 |
Ejemplares similares
-
The Role of Immunity in the Pathogenesis of SARS-CoV-2 Infection and in the Protection Generated by COVID-19 Vaccines in Different Age Groups
por: Abdulla, Zainalabideen A., et al.
Publicado: (2023) -
Isolation of Histoplasma capsulatum and Blastomyces dermatitidis from Iraqi Patients with Lower Respiratory Tract Infections
por: Yehia, Manahil M., et al.
Publicado: (2011) -
2016 Availability summary
por: Apollonio, A, et al.
Publicado: (2017) -
2015 availability summary
por: Apollonio, A, et al.
Publicado: (2016) -
Summary of the Available Molecular Methods for Detection of SARS-CoV-2 during the Ongoing Pandemic
por: Arena, Fabio, et al.
Publicado: (2021)